Impax Receives Tentative FDA Approval of Generic Coreg CR(R) (Carvedilol Phosphate) Extended-Release Capsules

BRIDGEWATER, N.J., Dec. 8, 2017 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has received tentative U.S. Food and Drug Administration ("FDA") approva... Biopharmaceuticals, Generics, FDA Impax Laboratories, Coreg CR, carvedilol
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news